Therapeuticsmd Inc (TXMD)

Jun 10, 2026

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jun 10, 2026

Jun 10, 2026

TherapeuticsMD (TXMD) Nears Support Amid Modest Selling PressureIndex Put Call - newsline.com

Jun 10, 2026

Jun 10, 2026

TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance ZoneMomentum Trade - newsline.com

Jun 10, 2026

Jun 08, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jun 08, 2026

Jun 04, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jun 04, 2026

Jun 02, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 02, 2026

May 29, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

May 29, 2026

May 28, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Amid Operational ChallengesEarnings Per Share - newsline.com

May 28, 2026

May 27, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates, Stock DeclinesPost-Earnings Drift - newsline.com

May 27, 2026

May 27, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates by Wide Margin Amidst Operational Challenges - newsline.com

May 27, 2026

May 24, 2026

TXMD Q3 2023 Earnings: A Significant EPS Miss Amid No Reported RevenueLow Growth Earnings - newsline.com

May 24, 2026

May 22, 2026

TherapeuticsMD (TXMD) Edges Higher as Support Holds Near $2.01Post-Earnings Moves - Newser

May 22, 2026

May 17, 2026

What TherapeuticsMD TXMD flagged as biggest challenges ahead Q3 2023 EPS Misses ViewsBanking Earnings Report - The Legal Advocate

May 17, 2026

May 14, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

May 14, 2026

May 13, 2026

TherapeuticsMD Announces First Quarter 2026 Financial Results - BioSpace

May 13, 2026

May 13, 2026

TXMD Reports Strong Q1 Revenue Growth and Explores Strategic Alt - GuruFocus

May 13, 2026

May 12, 2026

Is TherapeuticsMD (TXMD) 13.4% Overvalued After Q1 2026 Earnings - GuruFocus

May 12, 2026

May 12, 2026

[10-Q] TherapeuticsMD, Inc. Quarterly Earnings Report - Stock Titan

May 12, 2026

May 12, 2026

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives - TipRanks

May 12, 2026

May 12, 2026

TherapeuticsMD: Q1 Earnings Snapshot - marketscreener.com

May 12, 2026

May 12, 2026

TherapeuticsMD swings to Q1 net income as license revenue rises - TradingView

May 12, 2026

May 12, 2026

TherapeuticsMD (TXMD) details Q1 2026 results and strategic review - Stock Titan

May 12, 2026

May 12, 2026

Drug-royalty owner TherapeuticsMD turns Q1 profit, explores sale, merger options - Stock Titan

May 12, 2026

May 10, 2026

What TherapeuticsMD (TXMD) flagged as biggest challenges ahead | Q3 2023: EPS Misses ViewsStock Trading Network - Newser

May 10, 2026

May 08, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 08, 2026

May 01, 2026

TXMD Stock Price, Quote & Chart | THERAPEUTICSMD INC (NASDAQ:TXMD) - ChartMill

May 01, 2026

Apr 24, 2026

TXMD Should I Buy - Intellectia AI

Apr 24, 2026

Apr 23, 2026

TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading.Trending Stock Ideas - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 22, 2026

TXMD Financials: Income Statement, Balance Sheet & Cash Flow | Therapeuticsmd Inc - Stock Titan

Apr 22, 2026

Apr 21, 2026

TXMD (TherapeuticsMD) shares gain 5.8 percent despite wider than expected Q3 2023 per share loss.Profit Guidance Range - newsline.com

Apr 21, 2026